- Home
- PODD vs ITCI Comparison
PODD vs ITCI Comparison
Compare PODD & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- ITCI
- Stock Information
- Founded
- PODD 2000
- ITCI 2002
- Country
- PODD United States
- ITCI United States
- Employees
- PODD N/A
- ITCI N/A
- Industry
- PODD Medical/Dental Instruments
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- PODD Health Care
- ITCI Health Care
- Exchange
- PODD Nasdaq
- ITCI Nasdaq
- Market Cap
- PODD 16.5B
- ITCI 13.5B
- IPO Year
- PODD 2007
- ITCI N/A
- Fundamental
- Price
- PODD $275.81
- ITCI $126.20
- Analyst Decision
- PODD Buy
- ITCI Buy
- Analyst Count
- PODD 16
- ITCI 13
- Target Price
- PODD $271.19
- ITCI $100.31
- AVG Volume (30 Days)
- PODD 533.0K
- ITCI 4.3M
- Earning Date
- PODD 02-20-2025
- ITCI 02-20-2025
- Dividend Yield
- PODD N/A
- ITCI N/A
- EPS Growth
- PODD 235.68
- ITCI N/A
- EPS
- PODD 5.74
- ITCI N/A
- Revenue
- PODD $1,983,900,000.00
- ITCI $613,728,000.00
- Revenue This Year
- PODD $23.56
- ITCI $48.41
- Revenue Next Year
- PODD $18.07
- ITCI $38.26
- P/E Ratio
- PODD $48.09
- ITCI N/A
- Revenue Growth
- PODD 27.42
- ITCI 46.08
- 52 Week Low
- PODD $160.19
- ITCI $62.78
- 52 Week High
- PODD $279.77
- ITCI $128.00
- Technical
- Relative Strength Index (RSI)
- PODD 61.05
- ITCI 85.88
- Support Level
- PODD $260.84
- ITCI $126.00
- Resistance Level
- PODD $274.45
- ITCI $128.00
- Average True Range (ATR)
- PODD 7.44
- ITCI 2.35
- MACD
- PODD 0.65
- ITCI 4.86
- Stochastic Oscillator
- PODD 88.34
- ITCI 96.18
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.